Page last updated: 2024-10-20

pyruvic acid and Leishmaniasis, Visceral

pyruvic acid has been researched along with Leishmaniasis, Visceral in 1 studies

Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marín, C1
Ramírez-Macías, I1
Rosales, MJ1
Muro, B1
Reviriego, F1
Navarro, P1
Arán, VJ1
Sánchez-Moreno, M1

Other Studies

1 other study available for pyruvic acid and Leishmaniasis, Visceral

ArticleYear
In vitro leishmanicidal activity of 1,3-disubstituted 5-nitroindazoles.
    Acta tropica, 2015, Volume: 148

    Topics: Acetates; Alanine; Animals; Antiprotozoal Agents; Glycine; In Vitro Techniques; Indazoles; Lactic Ac

2015